NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of WPP plc (NYSE: WPP). Shareholders who purchased shares of WPP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/wpp-plc-loss-submission-form/?id=177906&from=3 CLASS PERIOD: February 27, 2025 to July 8, 2025 ...

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Stride, Inc. for the period between October 22, 2024, and October 28, 2025, due to alleged misleading statements and omissions regarding the company's products and services [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Stride made misleading statements about its products and services, which were designed to help learners reach their full potential [5]. - Allegations include that Stride inflated enrollment numbers, cut staff costs beyond statutory limits, ignored compliance requirements, and lost existing and potential enrollments [5]. Group 2: Participation Information - Investors who purchased Stride securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

NEW YORK, Nov. 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of James Hardie Industries plc. (NYSE: JHX). Shareholders who purchased shares of JHX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. Accessibility StatementSkip Navigation SOURCE The Gross Law Firm CONTACT US HERE: https://securitiesclasslaw.com/securities/james-hardie ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against James Hardie Industries plc due to allegations of misleading investors regarding the performance of its North America Fiber Cement segment between May 20, 2025, and August 18, 2025 [3][4]. Company Performance - James Hardie reported a 29% decline in first-quarter profit for the period ending June 30, 2025, and projected lower-than-expected fiscal 2026 earnings, attributing this to high borrowing costs [3]. - The company falsely claimed that demand remained strong and that stock levels were "normal," despite knowing about distributor destocking by early May 2025 [3]. Market Reaction - Following the announcement of disappointing financial results, James Hardie's American Depositary Receipt (ADR) price fell by $9.79, or 34.44%, closing at $18.64 per ADR on August 20, 2025 [4]. Legal Proceedings - A federal securities class action has been filed against James Hardie, with a deadline of December 23, 2025, for investors to seek the role of lead plaintiff [1][5]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought by the class [5]. Additional Information - Faruqi & Faruqi encourages anyone with information regarding James Hardie's conduct to come forward, including whistleblowers and former employees [6].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fluor (FLR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Fluor securities between February 18, 2025 and July 31, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Ea ...

Core Viewpoint - Avantor, Inc. is facing a securities fraud class action lawsuit due to significant stock price declines following disappointing financial results and management changes, with a deadline for investors to file a lead plaintiff motion by December 29, 2025 [1][15]. Financial Performance - On April 25, 2025, Avantor reported first quarter results that missed consensus estimates and reduced guidance for the remainder of 2025, citing increased competitive intensity [2]. - Following this announcement, Avantor's stock price dropped by $2.57, or 16.6%, closing at $12.93 per share [3]. - On August 1, 2025, the company again missed estimates in its second quarter results, revealing a year-over-year decrease in net sales and further reducing its 2025 guidance [3][4]. - This led to a further decline in stock price by $2.08, or 15.5%, closing at $11.36 per share [4]. - On October 29, 2025, Avantor disclosed disappointing third quarter results, including a -5% organic revenue growth and a net loss of $712 million, primarily due to a non-cash goodwill impairment charge of $785 million [5]. - The stock price fell by $3.50, or 23.2%, closing at $11.58 per share following this announcement [6]. Lawsuit Details - The class action lawsuit alleges that Avantor made materially false and misleading statements and failed to disclose adverse facts about its business and competitive positioning [7]. - Specific allegations include that Avantor's competitive position was weaker than represented, and that the company was negatively impacted by increased competition, which contradicted the positive statements made by the defendants [7].

Core Viewpoint - Inspire Medical is facing a class action lawsuit due to alleged misleading statements regarding the launch of its Inspire V product, which reportedly encountered significant challenges and poor demand [3][4]. Summary by Sections Class Action Details - The class action is on behalf of investors who purchased securities between August 6, 2024, and August 4, 2025, with a deadline of January 5, 2025, for filing a lead plaintiff motion [1]. - Investors are encouraged to contact the Portnoy Law Firm for legal rights discussions and case evaluations [2]. Allegations Against Inspire Medical - The lawsuit claims that Inspire Medical made false statements about the successful launch of Inspire V, which was actually hindered by poor demand and excess inventory at provider centers [3]. - It is alleged that many centers did not complete necessary training and onboarding, which delayed the launch and billing processes for Medicare patients [4]. Impact on Financial Guidance - Following the revelation of these issues on August 4, 2025, Inspire Medical reduced its 2025 earnings guidance by over 80%, leading to a more than 32% decline in its stock price [4].

Core Viewpoint - A new lawsuit has been filed questioning Trump's trade policies, particularly the high tariffs imposed under the International Emergency Economic Powers Act, with potential implications for businesses seeking refunds if the government loses [2][3]. Group 1: Lawsuit Details - The lawsuit aims to establish a category of businesses importing products from China or the EU, which could lead to significant refunds, as the government estimates nearly $500 billion in tariff revenue for the fiscal year [3]. - This lawsuit is at least the second filed in the past week, with the Supreme Court set to hear related cases, indicating a growing legal challenge against the tariffs [3]. - The lawsuit could involve amounts exceeding $100 million, highlighting the financial stakes for affected businesses [3]. Group 2: Government's Position - The White House maintains that Trump legally exercised emergency tariff powers granted by Congress, expressing confidence in a favorable Supreme Court ruling [4]. - If the Supreme Court rules the tariffs illegal, businesses that have paid these tariffs could seek refunds, potentially complicating the refund process for the government [4]. - The current cases focus on the legal authority under which tariffs were imposed, with less emphasis on what remedial actions would follow if the tariffs are overturned [4]. Group 3: Legal Strategy - The New Civil Liberties Alliance, representing various businesses, is pursuing a collective lawsuit to ensure broad relief for all affected entities, as previous cases did not seek to confirm a wider class of plaintiffs [5][6]. - The organization aims to prepare for a comprehensive challenge against the tariffs, indicating a strategic approach to counter the government's potential piecemeal defenses [6].

Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the specified class period from February 18, 2025, to July 31, 2025 [3][7]. Allegation Details - The lawsuit claims that Fluor's management failed to disclose significant cost increases related to major projects, including the Gordie Howe, I-635/LBJ, and I-35 projects, due to subcontractor design errors, price increases, and scheduling delays [3]. - It is alleged that these issues, along with reduced capital spending from customers and economic uncertainty, were likely to have a significant negative impact on Fluor's business and financial results [3]. - The financial guidance provided by Fluor for FY 2025 is claimed to be unreliable and unrealistic, with an overstated effectiveness of the company's risk mitigation strategy and an understated impact of economic uncertainty [3]. Next Steps - Investors who purchased Fluor shares and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire for more information regarding their rights and potential claims [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is November 14, 2025 [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across various courts in the United States [5].

Core Points - The Gross Law Firm is notifying shareholders of WPP plc regarding a potential class action lawsuit due to misleading statements made by the company during a specified class period [1][3] - The class period for the allegations spans from February 27, 2025, to July 8, 2025, during which WPP is accused of providing overly positive statements while concealing adverse facts about its media arm's performance [3] - Following a trading update on July 9, 2025, WPP's stock price dropped significantly from $35.82 to $29.34, marking an approximate decline of 18.1% in one day due to the revelation of deteriorating performance [3] Allegations and Impact - The complaint alleges that WPP was not adequately equipped to handle macroeconomic challenges and was losing market share to competitors, which was not disclosed to investors [3] - The company's trading update indicated a deterioration in performance attributed to macroeconomic uncertainties and weaker new business, compounded by ongoing restructuring efforts [3] Next Steps for Shareholders - Shareholders are encouraged to register for the class action by December 8, 2025, to potentially become lead plaintiffs and receive updates on the case [4] - Registration involves no cost or obligation, and participants will be enrolled in a portfolio monitoring system for status updates [4] Firm Background - The Gross Law Firm is recognized for its commitment to protecting investors' rights against deceit and fraud, aiming to hold companies accountable for misleading practices [5]